Cutaneous mycobacterial infection post intravesical BCG installation.
Disseminated tuberculous lesions post intravesical BCG therapy are rare but need to be identified and treated quickly. We report the first case of a tuberculous cutaneous lesion in a patient receiving the above treatment.
Ng
Y H
YH
Department of Urology, Raigmore Hospital, Inverness, UK.
Bramwell
S P
SP
Palmer
T J
TJ
Woo
W K
WK
D000283:Administration, Intravesical; D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D001707:Biopsy, Needle; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005500:Follow-Up Studies; D006229:Hand Dermatoses / Q000209:etiology / Q000382:microbiology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D016896:Treatment Outcome; D014382:Tuberculosis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000995:Antitubercular Agents; D001500:BCG Vaccine